Capivasertib
Product Specifications
CAS Number
1143532-39-1
Target
PKA|||Akt|||mTOR|||Autophagy
Related Pathways
Autophagy|||Tyrosine Kinase/Adaptors|||PI3K/Akt/mTOR signaling|||Cytoskeletal Signaling
Purity
0.996
Bioactivity
Capivasertib (AZD5363) is a broad-spectrum AKT inhibitor with inhibitory activity against Akt1, Akt2, and Akt3 (IC50=3/7/7 nM) with oral activity. Capivasertib has antitumor activity for the treatment of breast cancer.
Smiles
NC1(CCN(CC1)c1ncnc2[nH]ccc12)C(=O)N[C@@H](CCO)c1ccc(Cl)cc1
Molecular Formula
C21H25ClN6O2
Molecular Weight
428.92
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6149327-01 0.1 mL
RHOBTB2 (DBC2, KIAA0717, Rho-related BTB Domain-containing Protein 2, Deleted in Breast Cancer 2 Gene Protein, p83) (FITC)
Ask
View Details 
MBS6149327-02 5x 0.1 mL
RHOBTB2 (DBC2, KIAA0717, Rho-related BTB Domain-containing Protein 2, Deleted in Breast Cancer 2 Gene Protein, p83) (FITC)
Ask
View Details 
